Related Experiment Video
Updated: Aug 26, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste
Dan Douer1, Kristy Watkins, Alexandra M Levine
1Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. douer_d@ccnt.hsc.usc.edu
Leukemia & Lymphoma
|February 13, 2004
Abstract:
Refractory AML patients have a very poor prognosis. Therefore, rationally designed new therapies, including clofarabine, are being investigated as potential treatments for this patient population. This is a case report of a patient with primary refractory AML who was treated with clofarabine and achieved a complete response.